首页> 中文期刊>中国继续医学教育 >生长抑素与泮托拉唑钠治疗重症急性胰腺炎的临床疗效分析

生长抑素与泮托拉唑钠治疗重症急性胰腺炎的临床疗效分析

     

摘要

目的:研究分析生长抑素与泮托拉唑钠联合应用对重症急性胰腺炎的治疗效果。方法选取2015年2月~2016年2月我院接收的126例重症急性胰腺炎的门诊患者并随机分为两组,对照组患者给予泮托拉唑钠进行治疗,实验组患者同时给予泮托拉唑钠和生长抑素进行治疗,治疗1个周期后观察两组患者的治疗效果以及并发症的出现情况并比较。结果实验组的治疗效果(95.2%)优于对照组(73.1%),且患者出现的并发症(4.8%)少于对照组(17.5%),运用SPSS 17.0软件分析得出P<0.05,差异具有统计学意义。结论生长抑素与泮托拉唑钠联合应用能显著缩短重症急性胰腺炎患者的恢复时间,治疗效果好且安全性高。%Objective To study the analysis of somatostatin and diazepam tora azole sodium combined use of therapeutic effect of severe acute pancreatitis.Methods From February 2015 to February 2016 in our hospital received 126 cases of severe acute pancreatitis patients were selected, and were randomly assigned to two groups, in control group were treated with pantoprazole sodium for treatment, patients in the experimental group while giving of pantoprazole and somatostatin treatment, after a period of treatment observation of the therapeutic effect of two groups of patients and complications were compared.Results The therapeutic effect of the experimental group (95.2%) was better than control group (73.1%), and complications (4.8%) patients is less than that of control group (17.5%), using SPSS 17.0 software analysis wasP<0.05, with statistical signiifcance. Conclusion Growth of somatostatin and pantoprazole sodium combined application can significantly shorten the recovery time of patients with severe acute pancreatitis, good curative effect and high safety.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号